source
- Serif Biomedicines claims breakthrough in non-viral gene therapy demonstrated in monkeysSerif Biomedicines, a startup launched by Flagship Pioneering last month, announced it believes it has overcome two key technical hurdles that have limited non-viral gene therapy. The company says…
- Alkermes reports Phase 3 success for Lumryz; Boehringer announces antibody partnershipAlkermes announced that its narcolepsy medication Lumryz, which received regulatory approval in 2023, achieved its primary efficacy endpoint in a Phase 3 trial. The study met the predefined criter…